Clinical Trial Update: Evaluating the Efficacy and Safety of Intra-articular Injection of HS-20116 in Patients With Knee Osteoarthritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intra-articular HS-20116 for knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• HS-20116

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Knee Osteoarthritis | Phase 3 | Status: COMPLETED